Conductive nanocomposite hydrogel and mesenchymal stem cells for the treatment of myocardial infarction and non-invasive monitoring via PET/CT

BACKGROUND: Injectable hydrogels have great promise in the treatment of myocardial infarction (MI); however, the lack of electromechanical coupling of the hydrogel to the host myocardial tissue and the inability to monitor the implantation may compromise a successful treatment. The introduction of c...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhu, Ke, Jiang, Dawei, Wang, Kun, Zheng, Danzha, Zhu, Ziyang, Shao, Fuqiang, Qian, Ruijie, Lan, Xiaoli, Qin, Chunxia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9077894/
https://www.ncbi.nlm.nih.gov/pubmed/35524274
http://dx.doi.org/10.1186/s12951-022-01432-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9077894/
https://www.ncbi.nlm.nih.gov/pubmed/35524274
http://dx.doi.org/10.1186/s12951-022-01432-7

Ejemplares similares